Drug Therapy

Changed

Tue, 12/13/2016 - 12:08

Display Headline

Introduction: Drug combinations for the treatment of hypertension

References

Article PDF

Author and Disclosure Information

Donald G. Vidt, MD
Section Editor, Senior physician, Department of Hypertension and Nephrology, The Cleveland Clinic Foundation

Alan Bakst, PharmD

Issue

Cleveland Clinic Journal of Medicine - 59(5)

Publications

Page Number

458-458

Read more about Introduction: Drug combinations for the treatment of hypertension

Sections

Author and Disclosure Information

Donald G. Vidt, MD
Section Editor, Senior physician, Department of Hypertension and Nephrology, The Cleveland Clinic Foundation

Alan Bakst, PharmD

Author and Disclosure Information

Donald G. Vidt, MD
Section Editor, Senior physician, Department of Hypertension and Nephrology, The Cleveland Clinic Foundation

Alan Bakst, PharmD

Article PDF

Article PDF

References

Issue

Cleveland Clinic Journal of Medicine - 59(5)

Issue

Cleveland Clinic Journal of Medicine - 59(5)

Page Number

458-458

Page Number

458-458

Publications

Publications

Article Type

Display Headline

Introduction: Drug combinations for the treatment of hypertension

Display Headline

Introduction: Drug combinations for the treatment of hypertension

Sections

Article Source

PURLs Copyright

Inside the Article

Article PDF Media

Adrenergic agents: clinical trials and experiences

Article Type

Changed

Tue, 12/13/2016 - 12:08

Display Headline

Adrenergic agents: clinical trials and experiences

References

Article PDF

Author and Disclosure Information

Donald G. Vidt, MD

Alan Bakst, PharmD

Lennart Hansson, MD, PhD

Address reprint requests to L.H., Department of Medicine, Őstia Hospital CK Plan 2, S-416 85, University of Göteborg, Göteborg, Sweden.

Issue

Cleveland Clinic Journal of Medicine - 59(3)

Publications

Page Number

248-254

Legacy Keywords

ADRENERGIC BETA RECEPTOR BLOCKADERS, HYPERTENSION

Read more about Adrenergic agents: clinical trials and experiences

Sections

Author and Disclosure Information

Donald G. Vidt, MD

Alan Bakst, PharmD

Lennart Hansson, MD, PhD

Address reprint requests to L.H., Department of Medicine, Őstia Hospital CK Plan 2, S-416 85, University of Göteborg, Göteborg, Sweden.

Author and Disclosure Information

Donald G. Vidt, MD

Alan Bakst, PharmD

Lennart Hansson, MD, PhD

Address reprint requests to L.H., Department of Medicine, Őstia Hospital CK Plan 2, S-416 85, University of Göteborg, Göteborg, Sweden.

Article PDF

Article PDF

References

Issue

Cleveland Clinic Journal of Medicine - 59(3)

Issue

Cleveland Clinic Journal of Medicine - 59(3)

Page Number

248-254

Page Number

248-254

Publications

Publications

Article Type

Display Headline

Adrenergic agents: clinical trials and experiences

Display Headline

Adrenergic agents: clinical trials and experiences

Legacy Keywords

ADRENERGIC BETA RECEPTOR BLOCKADERS, HYPERTENSION

Legacy Keywords

ADRENERGIC BETA RECEPTOR BLOCKADERS, HYPERTENSION

Sections

Article Source

PURLs Copyright

Inside the Article

Article PDF Media

The hemodynamic effects of adrenergic blocking agents

Article Type

Changed

Tue, 12/13/2016 - 12:08

Display Headline

The hemodynamic effects of adrenergic blocking agents

References

This article was produced by Consultants in Medical Education, Inc., Manhasset, New York, under an educational grant from Schering-Plough International.

Article PDF

Author and Disclosure Information

Donald G. Vidt, MD

Alan Bakst, PharmD

Per Lund-Johansen

Address reprint requests to P.L-J., Section of Cardiology, Medical Department, Haukeland Hospital, 5021 Bergen, Norway.

Issue

Cleveland Clinic Journal of Medicine - 59(2)

Publications

Page Number

193-200

Legacy Keywords

HEMODYNAMICS, HYPERTENSION, ADRENERGIC ALPHA RECEPTOR BLOCKERS, ADRENERGIC BETA RECEPTOR BLOCKERS

Read more about The hemodynamic effects of adrenergic blocking agents

Sections

Author and Disclosure Information

Donald G. Vidt, MD

Alan Bakst, PharmD

Per Lund-Johansen

Address reprint requests to P.L-J., Section of Cardiology, Medical Department, Haukeland Hospital, 5021 Bergen, Norway.

Author and Disclosure Information

Donald G. Vidt, MD

Alan Bakst, PharmD

Per Lund-Johansen

Address reprint requests to P.L-J., Section of Cardiology, Medical Department, Haukeland Hospital, 5021 Bergen, Norway.

Article PDF

Article PDF

References

This article was produced by Consultants in Medical Education, Inc., Manhasset, New York, under an educational grant from Schering-Plough International.

References

This article was produced by Consultants in Medical Education, Inc., Manhasset, New York, under an educational grant from Schering-Plough International.

Issue

Cleveland Clinic Journal of Medicine - 59(2)

Issue

Cleveland Clinic Journal of Medicine - 59(2)

Page Number

193-200

Page Number

193-200

Publications

Publications

Article Type

Display Headline

The hemodynamic effects of adrenergic blocking agents

Display Headline

The hemodynamic effects of adrenergic blocking agents

Legacy Keywords

HEMODYNAMICS, HYPERTENSION, ADRENERGIC ALPHA RECEPTOR BLOCKERS, ADRENERGIC BETA RECEPTOR BLOCKERS

Legacy Keywords

HEMODYNAMICS, HYPERTENSION, ADRENERGIC ALPHA RECEPTOR BLOCKERS, ADRENERGIC BETA RECEPTOR BLOCKERS

Sections

Article Source

PURLs Copyright

Inside the Article

Article PDF Media

Moricizine: pharmacodynamic, pharmacokinetic, and therapeutic profile of a new antiarrhythmic

Article Type

Changed

Tue, 12/13/2016 - 12:08

Display Headline

Moricizine: pharmacodynamic, pharmacokinetic, and therapeutic profile of a new antiarrhythmic

References

Article PDF

Author and Disclosure Information

Donald G. Vidt, MD

Alan Bakst, PharmD

Gabriel Vanerio, MD

James D. Maloney, MD

Address reprint requests to J.D.M., Department of Cardiology, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195.

Issue

Cleveland Clinic Journal of Medicine - 59(1)

Publications

Page Number

79-86

Legacy Keywords

MORICIZINE, ARRHYTHMIA

Read more about Moricizine: pharmacodynamic, pharmacokinetic, and therapeutic profile of a new antiarrhythmic

Sections

Author and Disclosure Information

Donald G. Vidt, MD

Alan Bakst, PharmD

Gabriel Vanerio, MD

James D. Maloney, MD

Address reprint requests to J.D.M., Department of Cardiology, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195.

Author and Disclosure Information

Donald G. Vidt, MD

Alan Bakst, PharmD

Gabriel Vanerio, MD

James D. Maloney, MD

Address reprint requests to J.D.M., Department of Cardiology, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195.

Article PDF

Article PDF

References

Issue

Cleveland Clinic Journal of Medicine - 59(1)

Issue

Cleveland Clinic Journal of Medicine - 59(1)

Page Number

79-86

Page Number

79-86

Publications

Publications

Article Type

Display Headline

Moricizine: pharmacodynamic, pharmacokinetic, and therapeutic profile of a new antiarrhythmic

Display Headline

Moricizine: pharmacodynamic, pharmacokinetic, and therapeutic profile of a new antiarrhythmic

Legacy Keywords

MORICIZINE, ARRHYTHMIA

Legacy Keywords

MORICIZINE, ARRHYTHMIA

Sections

Article Source

PURLs Copyright

Inside the Article

Article PDF Media

Treating hypertension to prevent coronary disease

Article Type

Changed

Tue, 12/13/2016 - 12:08

Display Headline

Treating hypertension to prevent coronary disease

References

Article PDF

Author and Disclosure Information

Donald G. Vidt, MD

Alan Bakst, PharmD

Norman M. Kaplan, MD

Address reprint requests to N.M.K., Department of Internal Medicine, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd., Dallas, TX 75235-8899.

Issue

Cleveland Clinic Journal of Medicine - 58(5)

Publications

Page Number

432-443

Legacy Keywords

CORONARY DISEASE, HYPERTENSION, BLOOD PRESSURE DETERMINATION

Read more about Treating hypertension to prevent coronary disease

Sections

Author and Disclosure Information

Donald G. Vidt, MD

Alan Bakst, PharmD

Norman M. Kaplan, MD

Address reprint requests to N.M.K., Department of Internal Medicine, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd., Dallas, TX 75235-8899.

Author and Disclosure Information

Donald G. Vidt, MD

Alan Bakst, PharmD

Norman M. Kaplan, MD

Address reprint requests to N.M.K., Department of Internal Medicine, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd., Dallas, TX 75235-8899.

Article PDF

Article PDF

References

Issue

Cleveland Clinic Journal of Medicine - 58(5)

Issue

Cleveland Clinic Journal of Medicine - 58(5)

Page Number

432-443

Page Number

432-443

Publications

Publications

Article Type

Display Headline

Treating hypertension to prevent coronary disease

Display Headline

Treating hypertension to prevent coronary disease

Legacy Keywords

CORONARY DISEASE, HYPERTENSION, BLOOD PRESSURE DETERMINATION

Legacy Keywords

CORONARY DISEASE, HYPERTENSION, BLOOD PRESSURE DETERMINATION

Sections

Article Source

PURLs Copyright

Inside the Article

Article PDF Media

Managing the hypertensive patient: reasonable goals

Article Type

Changed

Tue, 12/13/2016 - 12:08

Display Headline

Managing the hypertensive patient: reasonable goals

References

Article PDF

Author and Disclosure Information

Donald G. Vidt, MD
Section Editor, Chairman, Department of Hypertension and Nephrology, The Cleveland Clinic Foundation

Alan Bakst, PharmD

Issue

Cleveland Clinic Journal of Medicine - 58(5)

Publications

Page Number

431-431

Read more about Managing the hypertensive patient: reasonable goals

Sections

Author and Disclosure Information

Donald G. Vidt, MD
Section Editor, Chairman, Department of Hypertension and Nephrology, The Cleveland Clinic Foundation

Alan Bakst, PharmD

Author and Disclosure Information

Donald G. Vidt, MD
Section Editor, Chairman, Department of Hypertension and Nephrology, The Cleveland Clinic Foundation

Alan Bakst, PharmD

Article PDF

Article PDF

References

Issue

Cleveland Clinic Journal of Medicine - 58(5)

Issue

Cleveland Clinic Journal of Medicine - 58(5)

Page Number

431-431

Page Number

431-431

Publications

Publications

Article Type

Display Headline

Managing the hypertensive patient: reasonable goals

Display Headline

Managing the hypertensive patient: reasonable goals

Sections

Article Source

PURLs Copyright

Inside the Article

Article PDF Media

Omeprazole: a new drug for the treatment of acid-peptic diseases

Article Type

Changed

Tue, 12/13/2016 - 12:08

Display Headline

Omeprazole: a new drug for the treatment of acid-peptic diseases

References

Article PDF

Author and Disclosure Information

Donald G. Vidt, MD

Alan Bakst, PharmD

Gary W. Falk, MD

Address reprint requests to G.W.F., Department of Gastroenterology, The Cleveland Clinic Foundation, One Clinic Center, 9500 Euclid Avenue, Cleveland OH 44195.

Issue

Cleveland Clinic Journal of Medicine - 58(5)

Publications

Page Number

418-428

Legacy Keywords

OMEPRAZOLE, CLINICAL PHARMACOLOGY

Read more about Omeprazole: a new drug for the treatment of acid-peptic diseases

Sections

Author and Disclosure Information

Donald G. Vidt, MD

Alan Bakst, PharmD

Gary W. Falk, MD

Address reprint requests to G.W.F., Department of Gastroenterology, The Cleveland Clinic Foundation, One Clinic Center, 9500 Euclid Avenue, Cleveland OH 44195.

Author and Disclosure Information

Donald G. Vidt, MD

Alan Bakst, PharmD

Gary W. Falk, MD

Address reprint requests to G.W.F., Department of Gastroenterology, The Cleveland Clinic Foundation, One Clinic Center, 9500 Euclid Avenue, Cleveland OH 44195.

Article PDF

Article PDF

References

Issue

Cleveland Clinic Journal of Medicine - 58(5)

Issue

Cleveland Clinic Journal of Medicine - 58(5)

Page Number

418-428

Page Number

418-428

Publications

Publications

Article Type

Display Headline

Omeprazole: a new drug for the treatment of acid-peptic diseases

Display Headline

Omeprazole: a new drug for the treatment of acid-peptic diseases

Legacy Keywords

OMEPRAZOLE, CLINICAL PHARMACOLOGY

Legacy Keywords

OMEPRAZOLE, CLINICAL PHARMACOLOGY

Sections

Article Source

PURLs Copyright

Inside the Article

Article PDF Media

Alpha- and beta-blocking agents: pharmacology and properties

Article Type

Changed

Tue, 12/13/2016 - 12:08

Display Headline

Alpha- and beta-blocking agents: pharmacology and properties

References

Article PDF

Author and Disclosure Information

Donald G. Vidt, MD

Alan Bakst, PharmD

B.N.C. Prichard

Address reprint requests to B.N.C.P., Head, Department of Clinical Pharmacology, University College London, 5 University Street (The Rayne Institute), London WCIE 6JJ, England.

Issue

Cleveland Clinic Journal of Medicine - 58(4)

Publications

Page Number

337-350

Legacy Keywords

ALPHA BLOCKERS, BETA BLOCKERS, HYPERTENSION

Read more about Alpha- and beta-blocking agents: pharmacology and properties

Sections

Author and Disclosure Information

Donald G. Vidt, MD

Alan Bakst, PharmD

B.N.C. Prichard

Address reprint requests to B.N.C.P., Head, Department of Clinical Pharmacology, University College London, 5 University Street (The Rayne Institute), London WCIE 6JJ, England.

Author and Disclosure Information

Donald G. Vidt, MD

Alan Bakst, PharmD

B.N.C. Prichard

Address reprint requests to B.N.C.P., Head, Department of Clinical Pharmacology, University College London, 5 University Street (The Rayne Institute), London WCIE 6JJ, England.

Article PDF

Article PDF

References

Issue

Cleveland Clinic Journal of Medicine - 58(4)

Issue

Cleveland Clinic Journal of Medicine - 58(4)

Page Number

337-350

Page Number

337-350

Publications

Publications

Article Type

Display Headline

Alpha- and beta-blocking agents: pharmacology and properties

Display Headline

Alpha- and beta-blocking agents: pharmacology and properties

Legacy Keywords

ALPHA BLOCKERS, BETA BLOCKERS, HYPERTENSION

Legacy Keywords

ALPHA BLOCKERS, BETA BLOCKERS, HYPERTENSION

Sections

Article Source

PURLs Copyright

Inside the Article

Article PDF Media

The continuing development of antihypertensive drugs

Article Type

Changed

Tue, 12/13/2016 - 12:08

Display Headline

The continuing development of antihypertensive drugs

References

Article PDF

Author and Disclosure Information

Donald G. Vidt, MD

Alan Bakst, PharmD

Issue

Cleveland Clinic Journal of Medicine - 58(4)

Publications

Page Number

335-335

Read more about The continuing development of antihypertensive drugs

Sections

Author and Disclosure Information

Donald G. Vidt, MD

Alan Bakst, PharmD

Author and Disclosure Information

Donald G. Vidt, MD

Alan Bakst, PharmD

Article PDF

Article PDF

References

Issue

Cleveland Clinic Journal of Medicine - 58(4)

Issue

Cleveland Clinic Journal of Medicine - 58(4)

Page Number

335-335

Page Number

335-335

Publications

Publications

Article Type

Display Headline

The continuing development of antihypertensive drugs

Display Headline

The continuing development of antihypertensive drugs

Sections

Article Source

PURLs Copyright

Inside the Article

Article PDF Media

Tailoring antihypertensive therapy in 1991

Article Type

media_4dc1728_ccjm58_3-0277.pdf

Changed

Tue, 12/13/2016 - 12:08

Display Headline

Tailoring antihypertensive therapy in 1991

References

Article PDF

Author and Disclosure Information

Donald G. Vidt, MD

Address reprint requests to D.G.V., Department of Hypertension and Nephrology, The Cleveland Clinic Foundation, One Clinic Center, 9500 Euclid Avenue, Cleveland, Ohio 44195.

Alan Bakst, PharmD

Issue

Cleveland Clinic Journal of Medicine - 58(3)

Publications

Page Number

277-284

Legacy Keywords

HYPERTENSION, THERAPY

Read more about Tailoring antihypertensive therapy in 1991

Sections